The scale of the problem is striking. After adjusting for age and sex, the researchers calculated an incidence rate of 3,488 cases per 10,000 children per year across the five selected cities. In practical terms, that means roughly one in every three children under five in these urban populations required emergency care, hospitalization, or intensive care for an acute respiratory infection within a single year. The figure underscores how ubiquitous these infections are in early childhood, a period when immature airways, developing immune systems, and frequent exposure to circulating viruses converge to make respiratory illness the leading reason for pediatric medical attention worldwide.

The study was designed as a descriptive, ecological analysis covering the full calendar year from January 1 to December 31, 2018. The team mined administrative records from Colombia’s national health system, including the Integrated Social Protection Information System known as SISPRO, to identify every case of acute respiratory infection that resulted in emergency department attendance, hospital admission, or intensive care unit admission. Cases were classified using the International Classification of Diseases, 10th Revision, alongside Colombia’s own Unified Medicine Coding and Common Unified Procedure Coding System, allowing the researchers to link clinical diagnoses, levels of care, and mortality outcomes across the entire care pathway. Because the analysis relied on fully anonymized administrative data rather than direct patient contact, the Medical Ethics Committee at Universidad de La Sabana granted approval without requiring individual informed consent, in line with Colombian biomedical research law and the Declaration of Helsinki.

The median age of children in the studied sample was two years, but age proved to be a decisive factor in how severe the disease became. Children who required intensive care were significantly younger than those who did not, with a median age of just one year in the ICU group compared with two years in the non-ICU group, a difference that was highly statistically significant. This gradient of vulnerability with decreasing age is a recurring theme in pediatric respiratory medicine, and the Colombian data confirm it with unusual clarity because of the sheer size of the population examined. The youngest infants, whose small airways are most easily obstructed by inflammation and whose immune defenses are least experienced, consistently occupied the most severe end of the disease spectrum.

When the researchers examined which diagnoses dominated, bacterial pneumonia emerged as the single most common clinical diagnosis across the cohort. Among viral causes, respiratory syncytial virus, or RSV, stood out as the leading etiological agent, and its dominance was particularly pronounced among children admitted to intensive care. RSV is well known to pediatricians as the classic cause of bronchiolitis, an infection that clogs the tiny bronchioles of infants with mucus and cellular debris, and the Colombian findings align with decades of international evidence placing RSV at the center of severe infant respiratory disease. The convergence of high bacterial pneumonia incidence and heavy RSV circulation in the same population highlights a dual burden: a virus that fills pediatric intensive care units and a bacterial pathology that generates the largest overall volume of serious cases.

Mortality in the cohort was low in absolute terms but sharply patterned by age and diagnosis. The highest death rate was observed in children under one year of age, at 0.2 percent, a figure that was statistically significant. Within that group, bronchiolitis carried the highest case fatality at 0.3 percent, followed by bacterial pneumonia at 0.1 percent, both reaching statistical significance. Among children who reached the intensive care unit, mortality rose to 0.8 percent, again a significant finding. Notably, although RSV was the most common viral etiology overall and dominated ICU admissions, only a single death in the dataset was attributed to the virus, suggesting that with adequate supportive care, including the oxygen therapy and mechanical ventilation available in Colombian pediatric intensive care, most children infected even with the most dangerous respiratory virus can survive.

Seasonality emerged as another defining feature of the epidemic landscape. The study found that incidence peaks aligned with Colombia’s rainy season, a pattern the authors link to climatic conditions documented by the Institute of Hydrology and Environmental Studies, known by its Spanish acronym IDEAM. In tropical countries, respiratory virus transmission does not follow the winter rhythm familiar from temperate latitudes; instead, increases in rainfall and humidity create conditions favorable to viral survival and transmission, while keeping children crowded indoors. For health system planners, this seasonal signature is invaluable: it defines predictable windows when emergency services, hospital beds, and pediatric intensive care capacity come under maximum pressure, and when preventive measures such as RSV immunization campaigns would deliver the greatest benefit if timed appropriately.

The methodological strength of the work lies in its comprehensiveness. Rather than relying on sentinel sites or voluntary reporting, which can distort the apparent burden of disease, the researchers harnessed the administrative infrastructure of Colombia’s universal health system, in which Healthcare Insurers, or EPS, register affiliations through the Unique Registry of Affiliates and procedures are coded through standardized national systems. This allowed the team to assemble a near-complete picture of severe respiratory disease across five major cities simultaneously. The trade-off inherent in ecological and administrative designs is that coding accuracy depends on clinical documentation, and the study cannot establish individual-level causal relationships between exposures and outcomes. Nevertheless, for measuring the magnitude and distribution of a disease burden, population-scale administrative data of this kind are among the most powerful tools available to epidemiologists.

The findings arrive at a moment of rapid change in the global response to pediatric respiratory disease. RSV prevention has been transformed in recent years by the approval of long-acting monoclonal antibodies for infants and of maternal vaccines, giving countries for the first time practical tools to blunt the annual RSV surge. The Colombian data provide exactly the kind of local evidence that national authorities need to decide how and when to deploy such interventions: they identify infants under one year, and especially those with bronchiolitis, as the group at highest risk of death, and they pinpoint the rainy season as the period of peak transmission. The authors argue that targeted interventions, improved surveillance, and healthcare strategies tailored to the country’s specific epidemiology are essential to reducing the impact of these infections on the most vulnerable children.

Beyond its immediate policy implications, the study fills an important gap in the scientific literature. The authors note that clinical data on viral etiology and outcomes in Latin America have been scarce, leaving the region underrepresented in the global estimates produced by initiatives such as the Global Burden of Disease project and the World Health Organization’s respiratory illness surveillance. By documenting an adjusted incidence approaching 3,500 severe cases per 10,000 children per year, a clear age gradient in severity, a dominant viral pathogen, and a mortality profile concentrated in the first year of life, the Colombian team has supplied a benchmark against which other countries in the region can now measure themselves. As RSV immunization programs roll out across Latin America in the coming years, studies of this kind will serve as the baseline that determines whether those investments are actually reducing the toll of severe respiratory disease on the region’s youngest children.

Subject of Research: Epidemiology of severe acute respiratory infections in children under five in Colombia

Article Title: Patterns of severe acute respiratory infections in children under five years old in Colombia: an ecological study

Article References: Sanabria-Herrera, N., Agudelo, S., Gutiérrez, J. D., Gutiérrez, V. A., & Oliveros, H. (2026). Patterns of severe acute respiratory infections in children under five years old in Colombia: an ecological study. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07576-x

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07576-x

Keywords: acute respiratory infections, Colombia, children under five, RSV, bacterial pneumonia, bronchiolitis, pediatric epidemiology, intensive care, seasonality, surveillance, public health, Latin America

The research team, led by investigators from the Infectious Diseases Research Center of Niigata University in Myanmar in collaboration with Myanmar’s National Health Laboratory and Thingangyun General Hospital, enrolled 646 outpatients presenting with acute respiratory infections at two Yangon hospitals between June and November 2024, a period spanning the country’s rainy season. The enrolled patients had a median age of just 3.7 years, reflecting the heavy toll that respiratory illness takes on young children in the region. Nasopharyngeal swabs collected from each participant were first screened using rapid diagnostic tests targeting three of the most clinically significant respiratory viruses: influenza, respiratory syncytial virus (RSV), and SARS-CoV-2. This two-tiered diagnostic strategy allowed the investigators to combine the speed and accessibility of point-of-care testing with the sensitivity and breadth of modern molecular platforms.

Of the 646 samples collected, at least one respiratory pathogen was detected in 548 cases, an overall detection rate of 84.8 percent. This strikingly high proportion confirms that during the rainy season, acute respiratory infections in Yangon are overwhelmingly viral in origin, with only a minority of cases attributable to non-viral causes or to pathogens outside the panel tested. The rapid diagnostic tests returned positive results for 331 specimens, and these were subsequently confirmed by real-time reverse transcription polymerase chain reaction (RT-PCR), the reference standard for respiratory virus detection. Among the RDT-positive specimens, influenza A(H3N2) dominated, accounting for 40.5 percent of detections, followed by RSV subtype A at 21.5 percent and influenza B/Victoria lineage at 20.2 percent. A single case of influenza A(H1N1)pdm09, the pandemic lineage that has circulated seasonally since 2009, was identified, representing just 0.3 percent of RDT-positive detections.

The 315 specimens that tested negative by rapid diagnostic tests were subjected to a far broader molecular interrogation using the BioFire FilmArray Respiratory 2.1 Panel, a multiplex PCR platform capable of detecting more than twenty respiratory pathogens simultaneously, including common coronaviruses, parainfluenza viruses, adenovirus, human rhinovirus and enterovirus, and human metapneumovirus (hMPV). Within this RDT-negative group, human rhinovirus/enterovirus emerged as the most prevalent pathogen, detected in 42.5 percent of specimens, while human metapneumovirus ranked second at 15.2 percent. These results highlight a critical limitation of narrow-panel screening: without multiplex molecular testing, a substantial fraction of the viral etiology of acute respiratory infections would have gone entirely unrecognized, particularly the contributions of rhinoviruses, enteroviruses, and hMPV, which are not covered by most rapid point-of-care assays.

Co-infections, in which more than one respiratory pathogen was detected in the same patient, were identified in 35 of the 229 BioFire-positive specimens, representing 15.3 percent of that subgroup. The frequency of co-detection raises important questions about viral interference, disease severity, and diagnostic interpretation, since the presence of multiple viruses in a single nasopharyngeal swab may reflect genuine simultaneous infection, sequential infection, or prolonged shedding from a prior illness. In pediatric populations such as the one studied in Yangon, where the median patient was under four years old, co-infections are a well-recognized feature of respiratory disease, and their documentation contributes to a more complete understanding of the viral ecology of the rainy season.

The temporal patterns observed across the six-month surveillance window were among the study’s most operationally significant findings. Influenza activity peaked in July and August, early in the rainy season, while RSV transmission followed a distinct trajectory, reaching its maximum in September. This staggered seasonality, with influenza and RSV peaking in separate months rather than coinciding, has direct implications for clinical preparedness, diagnostic capacity planning, and the timing of preventive interventions. For a tropical setting where respiratory virus seasonality does not follow the temperate winter pattern familiar in higher latitudes, defining these local peaks is essential for guiding when hospitals should anticipate surges in pediatric respiratory admissions and when vaccination campaigns, particularly against seasonal influenza, would deliver the greatest benefit.

Beyond pathogen detection, the study pursued viral genetic characterization to place the Yangon isolates within the global evolutionary context of circulating respiratory viruses. Influenza A(H3N2), A(H1N1)pdm09, and B/Victoria viruses with cycle threshold values below 32, indicating sufficiently high viral loads, underwent next-generation sequencing targeting the hemagglutinin gene, the principal surface antigen against which vaccine-induced and natural immunity are directed. Phylogenetic analysis revealed that the A(H3N2) sequences clustered within clades J.2, J.2.1, and J.2.2, the recently emerged subgroups that have dominated A(H3N2) circulation in many parts of the world. The B/Victoria sequences fell within subclade V1A.3a.2, primarily within the C.5.7 subgroup, while the single A(H1N1)pdm09 sequence belonged to clade C.1.9. These assignments demonstrate that the influenza viruses circulating in Yangon were genetically aligned with contemporary global lineages, information that is directly relevant to assessing the match between circulating strains and the composition of seasonal vaccines.

Perhaps the most notable genetic finding concerned human metapneumovirus, a paramyxovirus that has gained increasing attention as a significant cause of respiratory illness in young children and the elderly. Partial sequencing of the fusion (F) gene, the target of most hMPV genotyping efforts and the gene encoding a major surface glycoprotein, revealed a striking genotype shift between consecutive years: while specimens from 2023 showed a mixture of genotypes A2 and B1, the 2024 samples were predominantly genotype B2. Such inter-annual genotype turnover is a recognized feature of hMPV epidemiology, thought to reflect population-level immune pressure driving the successive dominance of antigenically distinct lineages. Documenting this shift in Myanmar provides valuable data for a region where hMPV genotype dynamics have been poorly characterized, and it illustrates how quickly the genetic composition of even lesser-studied respiratory viruses can change from one season to the next.

The broader significance of the study lies in what it reveals about the state of respiratory virus surveillance in Myanmar and comparable settings. Comprehensive molecular surveillance data from the country have long been limited, leaving public health authorities with an incomplete picture of pathogen distribution, seasonality, and viral evolution. By combining accessible rapid diagnostics with confirmatory RT-PCR, multiplex panel testing, and next-generation sequencing, the surveillance program established a layered diagnostic architecture that could serve as a model for other resource-constrained settings. The work was conducted under the framework of the Japan Initiative for Global Research Network on Infectious Diseases, funded by the Japan Agency for Medical Research and Development, reflecting the growing recognition that infectious disease threats in any region demand internationally collaborative, locally embedded laboratory capacity.

The study’s conclusions carry clear forward-looking implications. Multiple respiratory viruses co-circulated throughout the 2024 rainy season in Yangon, each following its own seasonal rhythm, and the genetic lineages detected were actively evolving in step with global trends. The authors emphasize that this ongoing viral genetic evolution, from the J.2 clade dominance in influenza A(H3N2) to the hMPV genotype shift toward B2, makes sustained molecular surveillance not merely desirable but necessary. Continuous monitoring of which viruses are circulating, when they peak, and how their genomes are changing provides the evidentiary foundation for vaccine strain selection, clinical guideline updates, and pandemic preparedness. For Myanmar, a country whose surveillance systems have faced substantial challenges, the demonstration that such integrated molecular monitoring is feasible during a single rainy season represents a meaningful step toward closing a long-standing gap in the global map of respiratory virus epidemiology.

Subject of Research: Molecular surveillance of respiratory viruses among outpatients with acute respiratory infections in Yangon, Myanmar

Article Title: Molecular surveillance of respiratory viruses among outpatients with acute respiratory infections in Yangon, Myanmar, during the 2024 rainy season

Article References: Win, S. M. K., Saito, R., Tamura, T., Ichikawa, Y., Matsuno, N., Kyaw, Y., Setk, S., Aye, M. M., Tin, H. H., Lwin, K. W., Linn, A. P., Oo, K. K., Mon, K. L., Sun, Y., Li, J., & Watanabe, H. (2026). Molecular surveillance of respiratory viruses among outpatients with acute respiratory infections in Yangon, Myanmar, during the 2024 rainy season. Virology Journal. https://doi.org/10.1186/s12985-026-03304-0

Image Credits: AI Generated

DOI: 10.1186/s12985-026-03304-0

Keywords: acute respiratory infections, molecular surveillance, influenza A(H3N2), respiratory syncytial virus, human metapneumovirus, rhinovirus, Myanmar, Yangon, rainy season, phylogenetics, next-generation sequencing, pediatric respiratory illness

The research team, led by co-first authors Duo Wang and Chunyang Dong under the supervision of Jianghua Zhang and Tian Chen, focused on a distinction that is often blurred in everyday conversation but is clinically meaningful: the difference between acute upper respiratory infections, abbreviated AURI, and acute lower respiratory infections, or ALRI. Upper respiratory infections encompass the common cold, pharyngitis, and similar ailments of the nose and throat, while lower respiratory infections include bronchitis and pneumonia, conditions that carry far greater global disease burden. According to recent analyses from the Global Burden of Disease Study 2021, both categories rank among the leading infectious causes of illness in children worldwide, which makes identifying modifiable environmental triggers a matter of considerable public health urgency.

Methodologically, the study harnessed the statistical machinery of generalized additive models, a flexible regression framework that has become a workhorse of air pollution epidemiology. The approach allows researchers to model daily counts of outpatient visits as a function of pollutant concentrations while simultaneously controlling for smooth, nonlinear trends in time, day of the week, and weather variables such as temperature and humidity. This matters because respiratory disease incidence follows strong seasonal rhythms driven by viral circulation and meteorology, and any credible analysis must disentangle those rhythms from the independent contribution of pollution. The team applied the framework to daily data from 2018 to 2019, linking pollutant measurements to outpatient visit counts classified by ICD-10 diagnostic codes for total respiratory diseases, AURI, and ALRI.

The findings on gaseous and particulate pollutants were striking in their specificity. Nitrogen dioxide and carbon monoxide, both hallmarks of combustion sources and especially of vehicular traffic, showed statistically significant positive associations with outpatient visits for total respiratory diseases and for acute upper respiratory infections. Particulate matter with an aerodynamic diameter of ten micrometers or less, known as PM10, was significantly associated with visits for both upper and lower respiratory infections, whereas the finer PM2.5 fraction, particles smaller than 2.5 micrometers, was significantly associated only with upper respiratory infections. Sulfur dioxide and ozone, by contrast, did not emerge as significant predictors in the main analysis, a pattern that may reflect the moderate concentration ranges typical of a coastal Chinese city that has implemented aggressive air quality controls over the past decade.

What elevates this study beyond many of its predecessors is its attention to the chemical anatomy of PM2.5. Fine particulate matter is not a single substance but a heterogeneous mixture whose toxicity depends on what, exactly, the particles are made of. The researchers analyzed water-soluble ions, including nitrate, ammonium, and sulfate, along with metal and metalloid components, and tested whether each constituent tracked with pediatric respiratory visits. In analyses based on a limited, non-continuous sampling framework comprising 174 sampling days, two ions stood out: nitrate and ammonium were significantly associated with outpatient visits for both total respiratory diseases and acute lower respiratory infections, while sulfate was significantly associated with lower respiratory infections alone. Notably, none of the measured metal or metalloid components showed statistically significant associations.

The identity of the significant ions is itself informative. Nitrate and ammonium in fine particles are largely secondary pollutants, formed in the atmosphere when nitrogen oxides from vehicle exhaust and industrial combustion react with ammonia, and their prominence in this study reinforces the signal already suggested by nitrogen dioxide and carbon monoxide. In other words, two independent lines of evidence, the gaseous tracer pollutants and the secondary inorganic aerosol constituents, converge on the same source category: combustion, and traffic in particular. Sulfate, which arises primarily from sulfur dioxide emissions associated with coal combustion and industrial processes, showed a narrower association restricted to lower respiratory infections, consistent with laboratory evidence that acidic and sulfate-rich particles provoke deeper lung inflammation.

Biologically, these results fit a coherent mechanistic picture. Fine particles penetrate deep into the respiratory tract, with the smallest fractions depositing in the bronchioles and alveoli, where they can trigger oxidative stress and inflammatory cascades. Experimental work has shown that acute nitrogen dioxide exposure enhances airway inflammation by modulating the balance between Th1 and Th2 immune responses and activating the JAK-STAT signaling pathway, effectively priming the airways for the viral infections that cause most acute respiratory illness. Children are particularly vulnerable because their airways are narrower, their immune systems are still maturing, and they breathe a greater volume of air per unit of body weight than adults, so a given ambient concentration delivers a proportionally larger dose to developing lungs.

The study’s authors are appropriately candid about its limitations, and the most important one concerns the constituent data. Because PM2.5 chemical speciation was available only on 174 non-continuous sampling days rather than every day of the study period, the component analyses rest on a smaller and less statistically powerful foundation than the pollutant analyses. The researchers also note that the study period of 2018 to 2019 predates the COVID-19 pandemic, and that outpatient visit records reflect healthcare-seeking behavior as well as underlying disease incidence, a factor that can vary with parental habits and access to care. Sensitivity analyses were conducted to probe the robustness of the main findings, and the core associations with nitrogen dioxide, carbon monoxide, and particulate matter held up under those checks.

Even with those caveats, the implications for policy are reasonably direct. The authors conclude that evaluations of the short-term respiratory health effects of ambient air pollution in children should consider PM2.5 chemical composition, not merely PM2.5 mass concentrations and gaseous pollutant levels. That recommendation carries weight for regulatory design: if nitrate and ammonium, both products of nitrogen oxide and ammonia chemistry, are the constituents doing much of the harm, then strategies targeting vehicle emissions, such as tighter exhaust standards, electrification of fleets, and control of ammonia from agricultural and industrial sources, may yield respiratory health dividends that a mass-based standard alone would fail to capture. Baoshan District, an industrial and port area of Shanghai, offers a telling test case for such interventions.

For parents and clinicians, the study adds to a growing body of evidence that bad air days and sick-child days are connected, particularly for the upper respiratory infections that account for the bulk of pediatric clinic visits. It joins a chorus of recent time-series analyses from Chinese cities and beyond, including work linking fine particles to childhood pneumonia emergency visits in Taiwan, to lower respiratory infection hospitalizations in Korea, and to respiratory syncytial virus hospitalizations in Poland. As monitoring networks expand to measure particle chemistry alongside particle mass, the picture of which pollutants sicken children, and where the most effective control levers lie, will only sharpen. In Shanghai’s case, the answer emerging from the data is clear: the traffic-sourced gases and the secondary particles they seed are the components most tightly woven into the fabric of children’s respiratory illness.

Subject of Research: Associations between ambient air pollutants, PM2.5 chemical components, and pediatric outpatient visits for acute respiratory infections in Shanghai

Article Title: Association of air pollutants and PM2.5 components with pediatric outpatient visits for acute respiratory infections in Baoshan District, Shanghai

Article References: Wang, D., Dong, C., Yang, C., Shi, Y., Chen, F., Wu, Z., Liu, M., Shen, X., Chen, T., & Zhang, J. (2026). Association of air pollutants and PM2.5 components with pediatric outpatient visits for acute respiratory infections in Baoshan District, Shanghai. Air Quality, Atmosphere & Health, 19(10), Article 212. https://doi.org/10.1007/s11869-026-02106-1

Image Credits: AI Generated

DOI: 10.1007/s11869-026-02106-1

Keywords: air pollution, PM2.5, nitrogen dioxide, carbon monoxide, PM2.5 components, children, acute respiratory infections, upper respiratory infection, lower respiratory infection, time-series analysis, Shanghai, public health